Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Scientific Reports|October 5, 2016
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysisLuca Trentin, Silvia Bresolin, Emanuela Giarin, et al.Plos One|November 3, 2010
Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALLBenedetta Accordi, Virginia Espina, Marco Giordan, et al.Oncotarget|July 16, 2014
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcomeGloria Milani, Paola Rebora, Benedetta Accordi, et al.Cancers|August 7, 2021
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric PatientsGiulia Veltri, Chiara Silvestri, Ilaria Gallingani, et al.Advances in Biological Regulation|March 27, 2018
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cellsJessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.Cell Death and Differentiation|July 22, 2020
Correction: JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD inductionLuca Simula, Mauro Corrado, Benedetta Accordi, et al.Cell Death and Differentiation|April 30, 2020
JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD inductionLuca Simula, Mauro Corrado, Benedetta Accordi, et al.Leukemia|February 24, 2018
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AMLMatteo Zampini, Claudia Tregnago, Valeria Bisio, et al.Neuro-Oncology|March 14, 2012
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastomaImmacolata Andolfo, Lucia Liguori, Pasqualino De Antonellis, et al.Oncotarget|July 9, 2020
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exitHee-Don Chae, Ritika Dutta, Bruce Tiu, et al.Pageof 4